Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders - Scahill, Lawrence; McCracken, James T.; Bearss, Karen; Robinson, Fay; Hollander, Eric; King, Bryan; Bregman, Joel; Sikich, Lin; Dukes, Kimberly; Sullivan, Lisa; Anagnostou, Evdokia; Donnelly, Craig; et al. (Journal of autism and developmental disorders, 2012)
Keywords: Adolescent; Age; Aggression; Antidepressants; Asperger Syndrome; Autism; Autistic children; Behavior Problems; Behavioral Science and Psychology; Biological and medical sciences; Child; Child and School Psychology; Child clinical studies; Child Development Disorders, Pervasive - drug therapy; Child Health; Children; Citalopram; Citalopram - therapeutic use; Clinical trials; Delayed Speech; Developmental Disabilities; Developmental disorders; Double-Blind Method; Drug Therapy; Female; Humans; Hyperactivity; Impressions; Infantile autism; Interpersonal Relationship; Literary Devices; Male; Medical sciences; Mental health; Mental Retardation; Networks; Neurodevelopmental disorders; Neurological disorders; Neuropharmacology; Neuropsychological Tests; Neurosciences; Original Paper; Outcomes of Treatment; Paediatrics; Pediatrics; Pervasive Developmental Disorders; Pharmaceutical industry; Pharmacology; Pharmacology. Drug treatments; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Public Health; Repetitive behaviour; Research Design; Research Subjects; Sample Size; Self destructive behavior; Serotonin Uptake Inhibitors - therapeutic use; Severity (of Disability); Social interaction; Stroke; Treatment Outcome; Young Children; United States; New York; United States--US; Autism; Double-blind method; Serotonin reuptake inhibitors; Repetitive behavior; Citalopram; Human; Trial; Serotonin; Psychotropic; Developmental disorder; Reuptake inhibitor; Selective serotonin reuptake inhibitor; Pervasive developmental disorder; Neurotransmitter; Double blind study; Antidepressant agent; Child